Filed with the SEC as Equels Thomas K; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: bought $27K of AIM. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $27KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
AIMBought: AIM ImmunoTech Inc. Nov 6, 202620,299 sharesfiled Nov 6, 2026210,046 shares held directly after, as filedfiling$3K
AIMBought: AIM ImmunoTech Inc. Oct 23, 202631,675 sharesfiled Oct 26, 2026189,747 shares held directly after, as filedfiling$5K
AIMBought: AIM ImmunoTech Inc. Oct 22, 202631,250 sharesfiled Oct 23, 2026158,072 shares held directly after, as filedfiling$5K
AIMBought: AIM ImmunoTech Inc. Sep 17, 202624,000 sharesfiled Sep 18, 2026126,822 shares held directly after, as filedfiling$5K
AIMBought: AIM ImmunoTech Inc. Sep 16, 202611,000 sharesfiled Sep 17, 2026102,822 shares held directly after, as filedfiling$2K
AIMBought: AIM ImmunoTech Inc. Sep 15, 202622,000 sharesfiled Sep 16, 202691,822 shares held directly after, as filedfiling$5K
AIMBought: AIM ImmunoTech Inc. Sep 14, 20265,900 sharesfiled Sep 15, 202669,822 shares held directly after, as filedfiling$1K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
